Samada SM

Language: Spanish
References: 6
Page: 156-158
PDF size: 101.53 Kb.

Text Extraction

No abstract.

REFERENCES

1. 1.Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ,Han SH, et al. Results of a prospective study of acute liverfailure at 17 tertiary care centers in the United States. AnnIntern Med. 2002;137:947-54.

2. Perdices EV, Martín-Ocaña F, Lucena MI, y R.J. Andrade RJ. Factores de riesgo y mecanismos de toxicidad hepática. Daño hepático inducido por medicamentos y tóxicos (excluido el alcohol). Medicine. 2012;11(10):573-80.

3. Lozano-Lanagrán M, Robles M, Andrade RJ. Hepatotoxicidad en 2011: progresando decididamente. Rev Esp Enferm Dig. 2011;103(9):472-9.

4. Fontana RJ. Approaches to the study of drug-induced liver injury. Clin Pharmacol Ther. 2010;88:416-9.

5. Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop. Hepatology. 2010;52:730-42.

6. Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardizationin drug-induced liver injury. Clin Pharmacol Ther. 2011;55:683-91.